Today: 9 April 2026
Abercrombie & Fitch stock slides 17% after outlook trim puts tariffs back on the tape
12 January 2026
1 min read

Abercrombie & Fitch stock slides 17% after outlook trim puts tariffs back on the tape

NEW YORK, Jan 12, 2026, 14:43 EST — Regular session

  • Shares of Abercrombie & Fitch tumbled following the company’s downgrade of its full-year sales growth forecast
  • Company revised its holiday-quarter outlook and highlighted tariff expenses baked into its guidance
  • Investors are eyeing this week’s ICR Conference for new insights on demand and pricing

Shares of Abercrombie & Fitch Co dropped 17.3% to $103.26 in afternoon trading Monday, following a cut to its full-year sales growth forecast and a more cautious holiday-quarter outlook. The stock had climbed as high as $124.75 earlier before falling to a session low of $98.87.

The reset came as apparel and footwear companies rolled out early holiday-quarter updates, highlighting a tougher consumer environment ahead of the ICR Conference. Consumer Edge analyst Michael Gunther noted that “value-seeking behavior was on full display” in this morning’s wave of retail pre-announcements, with shoppers— even those with higher incomes—continuing to favor cheaper options. Abercrombie’s forecast for roughly 5% sales growth in the fourth quarter falls short of the 5.8% increase that analysts had predicted, according to LSEG data cited by Reuters. Reuters

For Abercrombie, it wasn’t the magnitude of the revision that mattered as much as the fact it moved downward. Investors had priced in steady growth and flawless execution; so even a minor cut can sting when expectations are so high.

Abercrombie now forecasts fiscal 2025 net sales growth of at least 6%, down slightly from its previous 6% to 7% range, with an operating margin near 13% and earnings between $10.30 and $10.40 per share. For Q4, the company expects sales growth around 5% and earnings in the $3.50 to $3.60 per share range. It raised planned capital spending to roughly $245 million, while maintaining share repurchase plans at about $450 million for the year, including $100 million this quarter. The outlook factors in approximately $90 million in tariff expenses—equivalent to 170 basis points, or 1.7 percentage points, of sales after mitigation—and a $39 million pretax gain from a litigation settlement. CEO Fran Horowitz described quarter-to-date net sales through fiscal December as “record.” SEC

The margin line looks set to come under pressure next. Operating margin—which measures operating profit as a portion of sales—can shift rapidly when retailers ramp up promotions to drive traffic.

The risk here is clear. The company’s tariff calculations rely on trade policies from early January; any major changes in policy, enforcement, or new supply-chain issues could trigger yet another adjustment.

Investors will want to see how much of the profit forecast hinges on one-time items. The litigation settlement adds a lift to the full-year outlook, but it’s a one-off. Some portfolio managers will likely exclude it from their calculations.

Following that, the ICR Conference in Orlando runs through Jan. 14. Investors usually use this event to dig into retailers’ demand, pricing, and sourcing strategies. Fresh insights on tariffs or early January sales could nudge Abercrombie shares in one direction or another for the week ahead. icrconference.com

Stock Market Today

  • Thomson Reuters (TRI) Upgraded to Buy on Rising Earnings Estimates
    April 9, 2026, 2:13 PM EDT. Thomson Reuters (TRI) has been upgraded to a Zacks Rank #2 (Buy) due to an upward trend in earnings estimates, a key factor influencing stock price movements. The Zacks rating, based solely on changes in earnings potential, signals an improved business outlook. This upgrade reflects growing confidence among institutional investors, who adjust share valuations based on earnings revisions, leading to potential stock price gains. The company is expected to earn $4.40 per share for the fiscal year ending December 2026, in line with last year. This upgrade highlights the importance of tracking earnings estimate revisions as a strategy for investment decisions in the near term.

Latest article

Dow Jones Today: Industrial Average Climbs as Oil Retreats, but Inflation Risk Keeps Wall Street Wary

Dow Jones Today: Industrial Average Climbs as Oil Retreats, but Inflation Risk Keeps Wall Street Wary

9 April 2026
The Dow Jones rose 247.66 points to 48,155.97 by midday Thursday, following a surge linked to signs of Middle East de-escalation and Israeli plans for peace talks with Lebanon. Oil prices fell over $4 a barrel after Netanyahu’s remarks, but remain 40% above pre-conflict levels. Amazon climbed 4.3% on strong AI revenue. Traders now see only a 30% chance of a Fed rate cut by year-end, down from 56%.
US Stock Market Today: Wall Street Rises Again, but Oil and Fed Fears Keep the Rally on Edge

US Stock Market Today: Wall Street Rises Again, but Oil and Fed Fears Keep the Rally on Edge

9 April 2026
The Dow rose 337 points, or 0.7%, by 1 p.m. Thursday as oil prices retreated after Israel announced direct talks with Lebanon and hopes for a U.S.-Iran ceasefire steadied markets. Amazon shares climbed on news its AWS AI services topped $15 billion in annualized revenue. The Fed signaled possible rate hikes if inflation persists. Oil shipments through the Strait of Hormuz remained sharply reduced.
Amazon Stock Rises After Andy Jassy Reveals AWS AI Revenue, Defends $200 Billion Spend

Amazon Stock Rises After Andy Jassy Reveals AWS AI Revenue, Defends $200 Billion Spend

9 April 2026
Amazon shares rose 5% Thursday after CEO Andy Jassy revealed AWS’s AI services are generating over $15 billion annually and its chip business more than $20 billion. Jassy said much of AWS’s $200 billion in planned 2026 spending is backed by customer commitments, including a $100 billion OpenAI deal. He also highlighted deep job cuts and a push for smaller teams. Amazon now operates over 1 million robots and plans to launch its Leo satellite network in mid-2026.
Unilever Snaps Up Grüns to Deepen U.S. Wellness Push After McCormick Food Deal

Unilever Snaps Up Grüns to Deepen U.S. Wellness Push After McCormick Food Deal

9 April 2026
Unilever said Thursday it will acquire U.S. greens-supplement brand Grüns for an undisclosed sum, with the deal expected to close later this year pending approvals. Grüns was valued at about $500 million in a 2025 Series B round, according to Reuters. The purchase follows Unilever’s recent agreement to combine its food business with McCormick.
Lumentum Stock Nears $960 After JPMorgan, Mizuho Raise Targets on Nvidia AI Optics Demand

Lumentum Stock Nears $960 After JPMorgan, Mizuho Raise Targets on Nvidia AI Optics Demand

9 April 2026
Lumentum shares climbed Thursday after JPMorgan raised its price target to $950, following Mizuho’s hike to $930. The moves come after Nvidia agreed last month to invest $2 billion in Lumentum and make multibillion-dollar purchase commitments. Lumentum reported February quarter revenue of $665.5 million, up 65.5% year-over-year. An SEC filing showed Lumentum will swap 5.7 million shares for $474.6 million in convertible notes.
Merck (MRK) stock slides as JPMorgan conference tests deal buzz and vaccine risk
Previous Story

Merck (MRK) stock slides as JPMorgan conference tests deal buzz and vaccine risk

Sarepta stock sinks as Elevidys sales miss, flu delays spill into 2026
Next Story

Sarepta stock sinks as Elevidys sales miss, flu delays spill into 2026

Go toTop